ION BLUE Encyclopedia

GHK (Tripeptide-1)

Tripeptide-1 (GHK; glycyl-L-histidyl-L-lysine) is a naturally occurring tripeptide used in cosmetics. Much of the skin literature concerns its copper complex (copper tripeptide-1 / GHK-Cu, summarized separately); cited evidence for the copper-free tripeptide is largely in vitro and review-level.

Evidence: Preclinical

Reading time:2 min
Citations:4
Updated:October 5, 2026

Type

Peptide

INCI Name

Tripeptide Glycyl-L-histidyl-L-lysine (Gly-His-Lys), the copper-free form of the GHK tripeptide

Direct Answer

Tripeptide-1 (GHK; glycyl-L-histidyl-L-lysine) is a naturally occurring tripeptide used in cosmetics. Much of the skin literature concerns its copper complex (copper tripeptide-1 / GHK-Cu, summarized separately); cited evidence for the copper-free tripeptide is largely in vitro and review-level.

Summary Table

Evidence Level

Preclinical

AI Summary

GHK is a naturally occurring tripeptide (Gly-His-Lys) found in human plasma; this entry covers the copper-free form (the copper complex, GHK-Cu, is covered separately). The evidence base is preclinical: review and laboratory literature describe proposed roles in skin remodeling, wound healing, and gene expression, but much of the functional data concerns the copper-bound complex rather than the copper-free peptide, and independent controlled human outcome trials of the copper-free form are limited. Framed as studied, not established for defined clinical outcomes.

Key Information

Classification

Copper PeptidesSignal Peptides3 Mechanisms

Key Takeaways

  • Tripeptide-1 (GHK) is a naturally occurring tripeptide used in cosmetics
  • Most skin-appearance evidence concerns the copper complex GHK-Cu (covered separately)
  • Cited copper-free GHK evidence is in vitro and review-level

Scientific Overview

In Plain English

Tripeptide-1, also called GHK, is a small peptide the body produces and that is used in skincare. Most skin research is on its copper-bound form (GHK-Cu); for the copper-free peptide, the cited evidence is mainly laboratory (cell) studies and review summaries.

Scientific Details

Tripeptide-1 (GHK) is a glycyl-histidyl-lysine tripeptide. A review summarizes tissue-remodeling activity and indicates that controlled human skincare findings (skin firmness, elasticity, and fine-line and photodamage appearance) are largely described for the copper complex GHK-Cu. An in vitro study in human dermal fibroblasts reported that GHK and its copper complex reduced IGF-2-dependent TGF-beta1 secretion, relevant to scar-related signaling.

How It Works

GHK is described in research in relation to extracellular-matrix and tissue-remodeling signaling; the cited human skincare appearance findings are largely associated with the copper complex GHK-Cu rather than the copper-free peptide.

Mechanism of Action

Tissue-remodeling signaling

cell

Review and in vitro work describe GHK in relation to extracellular-matrix remodeling; the human appearance findings are largely associated with the copper complex.

Copper binding

cell

GHK binds copper(II) to form GHK-Cu; much of the peptide's described biological activity is attributed to the copper complex.

Gene-expression modulation

cell

Review and laboratory literature associate GHK/GHK-Cu with changes in expression of genes related to tissue remodeling and repair.

Evidence Level

Human Evidence

Human skincare appearance findings in the cited review are largely attributed to the copper complex (GHK-Cu), summarized separately.

Cell Evidence

An in vitro fibroblast study reported reduced TGF-beta1 secretion with GHK and its copper complex.

Limitations

For the copper-free tripeptide specifically, cited evidence is in vitro and review-level; much of the skin-appearance evidence concerns GHK-Cu.

Why This Grade

Graded preclinical: for the copper-free tripeptide specifically, the cited evidence is in vitro and review-level, with no human study — and much of the skin-appearance evidence in the literature concerns the copper complex GHK-Cu rather than the copper-free peptide. The grade reflects laboratory-level data that should not be read as human validation of copper-free GHK.

Frequently Asked Questions

What's the difference between GHK and GHK-Cu (copper peptide)?

GHK is the copper-free tripeptide glycyl-L-histidyl-L-lysine (INCI Tripeptide-1). GHK-Cu (INCI Copper Tripeptide-1) is the same peptide bound to copper. GHK binds copper to form GHK-Cu, and much of the peptide’s described biological activity is attributed to the copper complex. Most of the functional research — including wound-healing and gene-expression effects — concerns GHK-Cu rather than the copper-free peptide, and independent controlled human data specific to copper-free GHK are limited. This distinguishes the two forms; it is not a claim that either form is proven more effective in skincare.

How is GHK thought to work?

GHK binds copper(II) to form GHK-Cu, and much of its described biological activity is attributed to the copper complex. Review and laboratory literature associate GHK/GHK-Cu with changes in the expression of genes related to tissue remodeling and repair. These are cell- and animal-level findings rather than established human outcomes.

Is copper-free GHK proven to work in skincare?

Evidence specific to the copper-free peptide is limited. Most functional data concern the copper complex GHK-Cu; human evidence largely concerns GHK-Cu in topical/cosmetic contexts, and independent controlled human outcome data specific to copper-free GHK are limited, with effects not established for defined clinical endpoints. It is graded preclinical.

Can GHK be injected or used systemically?

Injectable or systemic use is not supported by controlled human safety data. GHK is used as a cosmetic (topical) ingredient and is not an approved medicine; evidence specific to the copper-free peptide is limited.

References

  1. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. (Authored by Loren Pickart of Skin Biology (Bellevue, WA) — a commercial copper-peptide manufacturer and GHK-Cu's principal researcher; narrative review, not a controlled clinical trial.)Reviewdoi:10.1163/156856208784909435 →
  2. Effect of GLY-HIS-LYS and its copper complex on TGF-beta secretion in normal human dermal fibroblasts. Acta Poloniae Pharmaceutica.Cell / In VitroPMID: 25745767 →
  3. The potential of GHK as an anti-aging peptide.Reviewdoi:10.31491/apt.2020.03.014 →
  4. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.Reviewdoi:10.34172/bi.30071 →

Alternative Names

  • GHK
  • Glycyl-L-histidyl-L-lysine
  • Gly-His-Lys
  • Tripeptide-1
  • GHK (copper-free)

Risks & Safety

  • Not an approved medicine; used as a cosmetic ingredient with the usual patch-test considerations
  • Evidence specific to the copper-free peptide is limited; most data concern GHK-Cu
  • Injectable or systemic use is not supported by controlled human safety data

Claim Boundaries

ION BLUE is an educational research aggregator. This content summarizes published scientific literature. It is not medically reviewed, is not medical advice, and is not a recommendation to use any substance. Several peptides discussed are research chemicals not approved for human use. Consult a licensed healthcare provider. Much skin-appearance evidence concerns the copper complex (GHK-Cu); this entry is not a recommendation to use the ingredient for any purpose.

This page summarizes published research and is for informational purposes only; it is not medical advice.

About ION BLUE

This encyclopedia is published by ION BLUE (“Peptides Done Precisely”). ION BLUE makes a GHK-Cu facial serum formulated at a disclosed 0.10% concentration, with no proprietary blends, fillers, or diluted formulations. The serum is in early access — join the list at ion-blue.com.